Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental dermatology 2021-12, Vol.46 (8), p.1612-1614
Hauptverfasser:	De Giorgi, V., Trane, L., Savarese, I., Silvestri, F., Venturi, F., Zuccaro, B., Scarfì, F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Monoclonal, Humanized - therapeutic use Basal cell carcinoma Carcinoma, Basal Cell - drug therapy Carcinoma, Basal Cell - pathology Ear Auricle - pathology Ear Neoplasms - drug therapy Ear Neoplasms - pathology Humans Immune Checkpoint Inhibitors - therapeutic use Immunotherapy Male Monoclonal antibodies Skin - pathology Skin cancer Skin Neoplasms - drug therapy Skin Neoplasms - pathology Targeted cancer therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!